ESR1 and breast cancer: Given the association of a surrogate measure of CIN, the CIN70 expression signature, with both numerical CIN and structural chromosomal complexity [11], we were able to determine that tumours from younger patients with breast cancer were more likely to be characterised by high CIN70 expression levels in both ER positive and ER negative breast cancer.